David M Kieras, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400 |
Dr. David Richard Dawson, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 32114 1st Ave S, Suite 103, Federal Way, WA 98003 Phone: 253-952-4576 Fax: 253-952-3416 |
Praveen Kanneganti, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S Ste 300, Federal Way, WA 98003 Phone: 253-838-8552 Fax: 253-272-0149 |
Gaston R Deysine, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400 |
Lawrence Wayne Snow, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 34709 9th Ave S Ste B500, Federal Way, WA 98003 Phone: 253-835-8800 |
Harrison Lakehomer, D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S Ste 300, Federal Way, WA 98003 Phone: 253-838-8552 Fax: 253-874-6089 |
Dr. Eric Scott Varley, D O Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400 Fax: 253-874-1637 |
Dr. Joshua Aaron Johnston, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Suite 300, Federal Way, WA 98003 Phone: 253-838-8552 Fax: 253-874-6089 |
Dr. Gary P. Hunter, D.O. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 34612 6th Ave S Ste 300, Federal Way, WA 98003 Phone: 253-838-8552 Fax: 253-874-6089 |
News Archive
Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and The Stanley Center for Psychiatric Research at Broad Institute, together with its international partners, are initiating major new sample collections in several regions and countries.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
For over 8 million children with asthma, food allergies and related conditions, the school-house is a focal point for managing their diseases. Now for the second year in a row, the Asthma and Allergy Foundation of America (AAFA) has released a report assessing school-based policies that address student health for elementary, middle and high schools in all 50 states.
Health and Human Services Secretary Kathleen Sebelius announced today that states and local organizations can apply for $40 million worth of outreach grants "to enroll more eligible children in health-insurance programs," according to the Wall Street Journal.
› Verified 3 days ago